BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1015 related articles for article (PubMed ID: 27349336)

  • 1. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Buse DC; Manack Adams A; Reed ML; Lipton RB
    Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
    Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Reed ML; Fanning KM; Kurth T; Lipton RB
    Headache; 2017 Jan; 57(1):31-44. PubMed ID: 27861837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Scher AI; Wang SJ; Katsarava Z; Buse DC; Fanning KM; Adams AM; Lipton RB
    Cephalalgia; 2019 Feb; 39(2):296-305. PubMed ID: 29996667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Serrano D; Holland S; Reed ML
    Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
    Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Bernstein JA; Lipton RB
    Cephalalgia; 2014 Apr; 34(5):336-48. PubMed ID: 24275145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
    Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC
    J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Manack AN; Reed ML; Buse DC; Varon SF; Lipton RB
    Value Health; 2013; 16(1):31-8. PubMed ID: 23337213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
    Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
    Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.